Torsten Klockenbring

Title: Torsten Klockenbring: Innovator in Anti-Plasmodium Antibodies

Introduction

Torsten Klockenbring is a notable inventor based in Bonn, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of novel human antibodies against malaria parasites. With a total of 3 patents to his name, Klockenbring's work is pivotal in the fight against malaria.

Latest Patents

Klockenbring's latest patents focus on anti-plasmodium parasite antibodies. The first patent describes a technology that relates to novel human antibodies against the malaria parasite, specifically targeting apical membrane antigen 1 (AMA-1). These antibodies exhibit high affinity for schizonts and merozoites, effectively inhibiting the reinvasion of merozoites into erythrocytes and neutralizing parasitic multiplication. The second patent also addresses anti-plasmodium parasite antibodies, this time targeting merozoite surface protein 10 (MSP10). Similar to the first, these antibodies have high affinity for schizonts and merozoites, contributing to the inhibition of parasitic growth.

Career Highlights

Klockenbring is associated with the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung E.V., a leading research organization in Germany. His work at this institution has allowed him to focus on innovative solutions to combat infectious diseases, particularly malaria.

Collaborations

Throughout his career, Klockenbring has collaborated with esteemed colleagues such as Stefan Barth and Rainer Fischer. These partnerships have enhanced the research and development of his innovative antibody technologies.

Conclusion

Torsten Klockenbring's contributions to the field of biotechnology, particularly in the development of anti-plasmodium antibodies, are invaluable. His work not only advances scientific knowledge but also plays a crucial role in addressing global health challenges.